Medicines and Healthcare Products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

820 requests
Make a Freedom of Information request to this authority
MHRA funding received from the Bill and Melinda Gates Foundation and and evidence of conditions attached.
Response by Medicines and Healthcare Products Regulatory Agency to Miriam Stevenson on .

Awaiting classification.

Our Ref: FOI 22/784 Dear Miriam Stevenson, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 26...
COVID-19 vaccine yellow card reporting
Response by Medicines and Healthcare Products Regulatory Agency to Richard Bottomley on .

Successful.

Dear Mr Bottomley, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines Division...
Packaging leaflet update and question regarding statistics.
Response by Medicines and Healthcare Products Regulatory Agency to Martin Brighty on .

Awaiting response.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Policies and standards for AI
Response by Medicines and Healthcare Products Regulatory Agency to James Sheppard on .

Partially successful.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Non-publication of COVID-19 vaccine iDAPs - Decision-makers
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .

Refused.

Dear Mr MacArthur Please find a response to your request for an internal review of FOI 21/794 attached. Kind regards, Chris MHRA Customer Experience...
Permission to publish COVID-19 vaccine iDAPs
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .

Partially successful.

Dear Mr MacArthur Please find a response to your request for an internal review of FOI 22/049 attached. Kind regards, Chris MHRA Customer Experience...
ADVERSE REACTIONS - Extracorporeal shock wave lithotripsy - KIDNEY
Response by Medicines and Healthcare Products Regulatory Agency to Mrs Butterworth on .

Awaiting classification.

Our Ref: FOI 22/776 Dear Mrs Butterworth, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 22 J...
Yellow card reports 2022 - SIRVA
Response by Medicines and Healthcare Products Regulatory Agency to Julia Holmes on .

Successful.

Dear Ms Holmes, Please find attached the response to your FOI request. Kind regards, FOI Team Vigilance and Risk Management of Medicines Division Me...
RNA integrity of experimental modRNA COVID-19 drugs (Pfizer and Moderna)
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .

Awaiting classification.

Dear Mr Weissman, We are writing in response to your request for a review of the Medicines and Healthcare products Regulatory Agency's ('the Agency')...
Pending Lawsuits involving MHRA
Response by Medicines and Healthcare Products Regulatory Agency to Kate Richards on .

Refused.

Our reference FOI 21/1334   Dear Kate Richards,   Thank you for your information request, dated 20th December 2021.  I am very sorry for the d...
Freedom of Information Act Review Performance
Response by Medicines and Healthcare Products Regulatory Agency to Michael Devlin on .

Successful.

FOI 22/697   Dear Mr Devlin,   Thank you for your email.   Please find answers to the questions you have raised below;     1.What is...
Yellow Card Scheme Awareness marketing, budget and Covid
Response by Medicines and Healthcare Products Regulatory Agency to Mr McCollum on .

Awaiting classification.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
health care assIstants
Response by Medicines and Healthcare Products Regulatory Agency to Michael Dobson on .

Awaiting classification.

Our Reference: CSC 104375 Dear Mr Dobson, Thank you for your email. We have reviewed your enquiry and this has been passed on to our Healthcare Qual...
Covid pathology request
Response by Medicines and Healthcare Products Regulatory Agency to Gian A. Ameri on .

Awaiting classification.

Internal Review of FOI 21/957 Dear Mr Ameri, Thank you for your email. Please find attached the response to your FOI Internal Review request. Kind...
Avicenna Plc (BRKR 42916)
Response by Medicines and Healthcare Products Regulatory Agency to Michael Devlin on .

Awaiting classification.

CSC 101054 Dear Mr Devlin, Thank you for your email. Yes the application form which you have provided is the evidence which didn't fall within secti...
Adverse Effects of Covid "Vaccination"
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .

Long overdue.

Internal Review of FOI 22/521 Dear Ms Jones, Thank you for your email. We confirm that an internal review will be carried out on FOI 22/521. We norm...
June Raine emails
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .

Awaiting response.

Our Ref: FOI 22/745 Dear Barbara Jones, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 8 June...
Access to Astra Zeneca trial date
Response by Medicines and Healthcare Products Regulatory Agency to Sheila Ward on .

Awaiting classification.

FOI 22/719 Dear Sheila Ward, Thank you for your email. The clinical data for the AstraZeneca vaccine is available through the EMA Clinical Database,...
Request for sight of the Astrazeneca trial data
Response by Medicines and Healthcare Products Regulatory Agency to C. Crichton on .

Awaiting classification.

FOI 22/720 Dear C.Crichton Thank you for your email. The clinical data for the AstraZeneca vaccine is available through the EMA Clinical Database, a...
How do you ensure that guidance provided to HCP's is acted on?
Response by Medicines and Healthcare Products Regulatory Agency to vikki spit on .

Awaiting classification.

Internal Review of FOI 22/452 Dear vikki spit, Thank you for your email. We confirm that an internal review will be carried out on FOI 22/452. We no...
Target Healthcare
Response by Medicines and Healthcare Products Regulatory Agency to John Watts on .

Awaiting classification.

FOI 22/682 Dear John Watts, Thank you for your information request, dated 10 May 2022, where you asked for: "Please can I have a copy of the post in...
How many medical products have been investigated for adverse effects since March 2020
Response by Medicines and Healthcare Products Regulatory Agency to Bob Parkinson on .

Refused.

Dear Dr Bob Parkinson,   Thank you for your email.   Please find attached the response to your internal review request for FOI 22/493   Ki...
Testerworld Limited
Response by Medicines and Healthcare Products Regulatory Agency to John Watts on .

Awaiting classification.

FOI 22/698 Dear Mr Watts, Thank you for your information request, dated 12 May 2022, where you asked for: "Please can I have a copy of all of the po...
PATENTS on corona virus
Response by Medicines and Healthcare Products Regulatory Agency to Ricci on .

Awaiting classification.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team. W...
Potential safety signals with COVID-19 vaccines
Request to Medicines and Healthcare Products Regulatory Agency by Kenneth MacArthur. Annotated by Chandra Singh on .

Refused.

Well, that was a surprise.

Only requests made using WhatDoTheyKnow are shown. ?